Cost-effectiveness of treatment and care of patients with gastrointestinal inflammatory diseases: a systematic review

Kristina Randlová et al.

Journal of Medical Economics2026https://doi.org/10.1080/13696998.2026.2637360article
ABDC C
Weight
0.50

What the paper says

Biologic therapies for inflammatory bowel disease are cost-effective, providing significant health benefits that offset higher costs. Substantial methodological heterogeneity and reliance on model-based economic evaluations limit direct comparability across studies. Future economic evaluations should focus on methodological consistency and transparency in assumptions to strengthen the interpretability of cost-effectiveness evidence.

Open paper page →

Cite this paper

https://doi.org/https://doi.org/10.1080/13696998.2026.2637360

Or copy a formatted citation

@article{kristina2026,
  title        = {{Cost-effectiveness of treatment and care of patients with gastrointestinal inflammatory diseases: a systematic review}},
  author       = {Kristina Randlová et al.},
  journal      = {Journal of Medical Economics},
  year         = {2026},
  doi          = {https://doi.org/https://doi.org/10.1080/13696998.2026.2637360},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

Cost-effectiveness of treatment and care of patients with gastrointestinal inflammatory diseases: a systematic review

Flags are reviewed by the Arbiter methodology team within 5 business days.


Evidence weight

0.50

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.50 × 0.4 = 0.20
M · momentum0.50 × 0.15 = 0.07
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.